144 related articles for article (PubMed ID: 8055447)
41. [Early relapse of Burkitt's lymphoma with t(8;14) and t(14;18) after rituximab-combined CODOX-M and IVAC therapy].
Fujishima N; Fujishima M; Inomata M; Yamanaka Y; Saitoh K; Kameoka Y; Yoshioka T; Saitoh H; Takahashi N; Hirokawa M; Sawada K
Rinsho Ketsueki; 2007 Apr; 48(4):326-31. PubMed ID: 17515125
[TBL] [Abstract][Full Text] [Related]
42. Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients.
Zimmermann H; Reinke P; Neuhaus R; Lehmkuhl H; Oertel S; Atta J; Planker M; Gärtner B; Lenze D; Anagnostopoulos I; Riess H; Trappe RU
Cancer; 2012 Oct; 118(19):4715-24. PubMed ID: 22392525
[TBL] [Abstract][Full Text] [Related]
43. Burkitt's lymphoma in the base of the tongue: differential diagnosis and management.
Manolopoulos L; Nikolopoulos TP; Yiotakis J; Karapatsas J; Maris A; Ferekidis E
ORL J Otorhinolaryngol Relat Spec; 2003; 65(4):226-9. PubMed ID: 14564099
[TBL] [Abstract][Full Text] [Related]
44. Ophthalmoparesis due to Burkitt's lymphoma following cardiac transplantation.
Liu GT; Kay MD; Byrne GE; Glaser JS; Schatz N
Neurology; 1993 Oct; 43(10):2147-9. PubMed ID: 8413988
[No Abstract] [Full Text] [Related]
45. [Ileocolonic invagination in an human immunodeficiency virus-positive man].
Pernas Souto B; López Calvo S; Mena de Cea Á; Pedreira Andrade JD
Gastroenterol Hepatol; 2014; 37(6):359-61. PubMed ID: 24786936
[No Abstract] [Full Text] [Related]
46. Treatment of poor prognosis Burkitt's lymphoma in adults with the Société Française d'Oncologie Pédiatrique LMB Protocol--a study of the Federation Nationale des Centres de Lutte Contre le Cancer (FNLCC).
Philip T; Meckenstock R; Deconnick E; Carrie C; Bailly C; Colombat P; Dauriac C; Demaille MC; Salles B; Cahn JY
Eur J Cancer; 1992; 28A(12):1954-9. PubMed ID: 1419288
[TBL] [Abstract][Full Text] [Related]
47. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
48. Intraocular involvement of Burkitt's lymphoma in a Bedouin child.
Wysenbeek YS; Nissenkorn I; Cohen S; Ben-Sira I; Stark B; Zaizov R
Pediatr Hematol Oncol; 1987; 4(4):309-14. PubMed ID: 3152936
[TBL] [Abstract][Full Text] [Related]
49. Excessive spinal cord toxicity from intensive central nervous system-directed therapies.
Watterson J; Toogood I; Nieder M; Morse M; Frierdich S; Lee Y; Moertel CL; Priest JR
Cancer; 1994 Dec; 74(11):3034-41. PubMed ID: 7954266
[TBL] [Abstract][Full Text] [Related]
50. Intensive sequential chemotherapy with hematopoietic growth factor support for non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus.
Costello RT; Zerazhi H; Charbonnier A; de Colella JM; Alzieu C; Poizot-Martin I; Cohen R; Bardou VJ; Xerri L; Olive D; Nezri M; Lepeu G; Gastaut JA
Cancer; 2004 Feb; 100(4):667-76. PubMed ID: 14770420
[TBL] [Abstract][Full Text] [Related]
51. Post-transplant Burkitt's leukemia or lymphoma. Study of five cases treated with specific intensive therapy (PETHEMA ALL-3/97 trial).
Xicoy B; Ribera JM; Esteve J; Brunet S; Sanz MA; Fernández-Abellán P; Feliu E
Leuk Lymphoma; 2003 Sep; 44(9):1541-3. PubMed ID: 14565657
[TBL] [Abstract][Full Text] [Related]
52. [Successful treatment with hyper-CVAD and highly active anti-retroviral therapy (HAART) for AIDS-related Burkitt lymphoma].
Suzuki K; Nakazato T; Sanada Y; Mihara A; Tachikawa N; Kurai H; Yoshimura Y; Hayashi H; Yoshida S; Kakimoto T
Rinsho Ketsueki; 2010 Mar; 51(3):207-12. PubMed ID: 20379116
[TBL] [Abstract][Full Text] [Related]
53. Toothache, paresthesia, and Horner syndrome: an unusual presentation of disseminated Burkitt's lymphoma.
Nissenbaum M; Kaban LB; Troulis MJ
J Oral Maxillofac Surg; 2007 Jul; 65(7):1395-401. PubMed ID: 17577512
[No Abstract] [Full Text] [Related]
54. Additional chemotherapy agents improve treatment outcome for children and adults with advanced B-cell lymphomas.
Adde M; Shad A; Venzon D; Arndt C; Gootenberg J; Neely J; Nieder M; Owen W; Seibel N; Wilson W; Horak ID; Magrath I
Semin Oncol; 1998 Apr; 25(2 Suppl 4):33-9; discussion 45-8. PubMed ID: 9578060
[TBL] [Abstract][Full Text] [Related]
55. Excellent immunological recovery following CODOX-M/IVAC, an effective intensive chemotherapy for HIV-associated Burkitt's lymphoma.
Montoto S; Wilson J; Shaw K; Heath M; Wilson A; McNamara C; Orkin C; Nelson M; Johnson M; Bower M; Cwynarski K
AIDS; 2010 Mar; 24(6):851-6. PubMed ID: 20124971
[TBL] [Abstract][Full Text] [Related]
56. Burkitt's lymphoma-- what is new?
Abinya ON
East Afr Med J; 2008 May; 85(5):205-6. PubMed ID: 18814529
[No Abstract] [Full Text] [Related]
57. Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. The Pediatric Oncology Group.
Crist W; Shuster J; Look T; Borowitz M; Behm F; Bowman P; Frankel L; Pullen J; Krance R; Steuber P
Leukemia; 1992; 6 Suppl 2():162-6. PubMed ID: 1578922
[TBL] [Abstract][Full Text] [Related]
58. African Burkitt's lymphoma: case report and light and electron microscopic findings.
Yih WY; Myers SL; Meshul CK; Bartley MH
Oral Surg Oral Med Oral Pathol; 1990 Dec; 70(6):760-4. PubMed ID: 2263336
[TBL] [Abstract][Full Text] [Related]
59. Effective prevention of central nervous system leukemia with intrathecal methotrexate and intrathecal methotrexate, cytosine arabinoside, and hydrocortisone in childhood acute lymphocytic leukemia.
Aur RJ; Hanna M; Sabbah R; Sackey K; Willoughby S; Atwood J
Haematol Blood Transfus; 1990; 33():504-10. PubMed ID: 2323651
[No Abstract] [Full Text] [Related]
60. Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
Lee EJ; Petroni GR; Schiffer CA; Freter CE; Johnson JL; Barcos M; Frizzera G; Bloomfield CD; Peterson BA
J Clin Oncol; 2001 Oct; 19(20):4014-22. PubMed ID: 11600602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
